A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms

European Journal of Epidemiology

Volumn 20, Issue 7, 2005, Pages 619-627

  Westbrook, Johanna I ^a   Duggan, Anne E ^b   Duggan, John M ^c   Westbrook, Mary T ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c Princeton Medical Centre   (Australia)

Author keywords

Dyspepsia; Endoscopy; Gastrooesophageal reflux disease; Outcomes; Treatment

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEMOGRAPHY; DETERIORATION; DIAGNOSTIC TEST; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; INTERVIEW; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PROSPECTIVE STUDY; TEACHING HOSPITAL; UPPER GASTROINTESTINAL TRACT;

ANALYSIS OF VARIANCE; AUSTRALIA; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; HISTAMINE ANTAGONISTS; HOSPITALS, TEACHING; HUMANS; INTERVIEWS; MALE; MEDICAL RECORDS; PROSPECTIVE STUDIES; PROTON PUMPS; RECEPTORS, HISTAMINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 23744510264     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-005-4304-5     Document Type: Article

References (31)

1. L Agreus 2002 Natural history of dyspepsia Gut 50 Suppl IV iv2 iv9
2. L Agreus 1995 Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time Gastroenterology 109 671 680
3. JG Penston RE Pounder 1996 A survey of dyspepsia in Great Britain Aliment Pharmacol Ther 10 83 89
4. J Westbrook J McIntosh N Talley 2000 Factors associated with consulting medical or non-medical practitioners for dyspepsia: An Australian population-based study Aliment Pharmacol Ther 14 1581 1588
5. G Tibblin 1985 Introduction to the epidemiology of dyspepsia Scand J Gastroenterol 20 Suppl 109 29 33
6. N.J Talley 1992 Dyspepsia and dyspepsia subgroups: A population-based study Gastroenterology 102 1259 1268
7. B Bernersen R Johnsen B Straume 1996 Non-ulcer dyspepsia and peptic ulcer: The distribution in a population and their relation to risk factors Gut 38 822 825
8. J Westbrook J McIntosh N Talley 2000 The impact of dyspepsia definition on prevalence estimates: Considerations for future researchers Scand J Gastroenterol 35 3 227 233
9. P Enck D Dubois P Marquis 1999 Quality of life in patients with upper gastrointestinal symptoms: Results from the Domestic International Gastroenterology Surveillance Study (DIGEST) Scand J Gastroenterol 34 Suppl 231 48 54
10. I Wilhelmsen 1999 On demand therapy of reflux oesophagitis - a prospective study of symptoms, patient satisfaction and quality of life Aliment Pharmacol Ther 13 1035 1040
11. J Westbrook N Talley M Westbrook 2002 Gender differences in the symptoms and health status of dyspeptics: A population based study Qual Life Res 11 3 283 291
12. P Bytzer J Moller Hansen O.B de Schaffalitzky Muckadell 1994 Empirical H2 -blocker therapy or prompt endoscopy in management of dyspepsia The Lancet 343 811 816
13. JI Westbrook 2002 Trends in the utilization of diagnostic upper gastrointestinal endoscopy in New South Wales, Australia 1988 - 1998 Gastrointest Endosc 55 7 195 202
14. J Westbrook A Duggan J McIntosh 2001 Prescriptions for antiulcer drugs in Australia: Volume, trends and costs Br Med J 323 1338 1339
15. Britt H, et al. General Practice Activity in Australia 1998 - 99. Canberra: Australian Institute of Health and Welfare, 1999
16. Swidley N, The costly case of the purple pill. Boston Globe Magazine, 2002. www.boston.com/globe/magazine/2002/1117/coverstory_entire.htm (Access April 2003)
17. Peterson L, Bauman N, The outlook for Prilosec and other proton pump inhibitors. Trends in Medicine. 2002, Stephen Snyder, Florida. www.trends-in-medicine.com
18. S.J.O van Veldhuyzen Zanten 1993 Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 46 3 273 279
19. T Johannessen 1993 The intensity and variability of symptoms in dyspepsia Scand J Prim Health Care 11 50 55
20. NJ Talley 1986 Randomised, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia Gastroenterology 91 149 156
21. JR Lambert 1989 Campylobacter pylori - a role in non-ulcer dyspepsia? Scand J Gastroenterol 24 suppl 160 7 13
22. J Westbrook 1998 Agreement between medical record data and patient accounts of their medical history and treatment for dyspepsia J Clin Epidemiol 51 3 237 244
23. N Schindlbeck 1992 Three year followup of patients with gastrooesophageal reflux disease Gut, 33 1016 1019
24. H Sloth LS Jorgensen 1988 Chronic non-organic upper abdominal pain: Diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms Scand J Gastroenterol 23 1275 1280
25. KD Bardhan 1993 Is there any acid peptic disease that is refractory to proton pump inhibitors? Ailment Pharmacol Therapy 7 Suppl 1 13 24
26. C Morris R Chapman R Mayou 1992 The outcome of unexplained dyspepsia J Psychosom Res 36 8 751 757
27. G Lindell F Celebioglu H Graffner 1995 Non-ulcer dyspepsia in the long-term perspective Eur J Gastroenterol Hepatol 7 829 833
28. J Hansen 1991 Efficacy and outcome of an open access endoscopy service Dan Med Bull 38 3 288 290
29. D Cantor 1982 Observer variability in upper gastrointestinal endoscopy Acta Gastroenterol Latin America 12 225 230
30. PA Kling K Edin L Domellof 1985 Observer variability in upper gastrointestinal fiber endoscopy Scand J Gastroenterol 20 462 465
31. P Bytzer T Havelund J Moller Hansen 1993 Interobserver variation in the endoscopic diagnosis of reflux esophagitis Scand J Gastroenterol 28 119 125